discontinue sulfonylurea when starting glp-1 receptor agonist Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects Beyond GLP-1 Agonists: An Adaptive
Description
31-33 Prevention of Retinopathy: One of the least-studied potential benefits of DPP-4 inhibitors is the ability to decrease blood flow and increase vasodilation, thereby preventing retinopathy in diabetic patients
In public comments, Lilly executives have highlighted that tirzepatide is exceeding growth expectations and driving record revenue
Acta 1832, 527541
NNT, number needed to treat
[DOI] [PubMed] [Google Scholar] 81.Korytkowski M.T., Muniyappa R., Antinori-Lent K., et al
Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy
